| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |